Actinogen Medical Limited (AU:ACW)

Actinogen Medical Limited (ACW) Financial Statements


Actinogen Medical Limited Financial Overview

Actinogen Medical Limited's market cap is currently ―. The company's EPS TTM is AU$-0.006; its P/E ratio is -4.78; Actinogen Medical Limited is scheduled to report earnings on August 28, 2024, and the estimated EPS forecast is AU$―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 22Jun 21Jun 20Jun 19Jun 18
Income Statement-
Total Revenue-----
Gross Profit-----
Net Income Common Stockholders-----
Balance Sheet-
Cash, Cash Equivalents and Short-Term InvestmentsAU$ 16.37MAU$ 13.42MAU$ 5.04MAU$ 7.64MAU$ 10.00M
Total AssetsAU$ 23.31MAU$ 18.38MAU$ 11.94MAU$ 16.22MAU$ 18.03M
Total DebtAU$ 165.27KAU$ 236.44KAU$ 389.87KAU$ 0.00AU$ 0.00
Net DebtAU$ -16.21MAU$ -13.19MAU$ -4.65MAU$ -7.64MAU$ -10.00M
Total LiabilitiesAU$ 1.57MAU$ 920.32KAU$ 1.05MAU$ 557.39KAU$ 768.25K
Stockholders EquityAU$ 21.74MAU$ 17.46MAU$ 10.89MAU$ 15.66MAU$ 17.26M
Cash Flow-
Free Cash Flow-----
Operating Cash Flow-----
Investing Cash Flow-----
Financing Cash Flow-----
Currency in AUD

Actinogen Medical Limited Earnings and Revenue History

Actinogen Medical Limited Debt to Assets

Actinogen Medical Limited Cash Flow

Actinogen Medical Limited Forecast EPS vs Actual EPS

What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis